Three years strong! Lundbeck US has been named a @FortuneMagazine Best Workplace in BioPharma for the third consecutive year, ranking #10 among large employers. This recognition belongs to our people, whose passion, purpose and commitment make our culture a superpower every day. Learn more:bit.ly/4dAQYVR

Join us October 14 in San Diego for the External Innovation & Partnering Event - an inspiring afternoon of science, networking and collaboration, focused on strengthening connections between Lundbeck and the San Diego biotech community to advance neuroscience innovation. The event offers an opportunity to discuss shared innovation priorities, scientific focus areas, and partnership opportunities as we look to advance innovation in neuroscience together. We are honored to welcome Dr. Ben Cravatt as our keynote speaker. As Professor and Norton B. Gilula Chair of Chemical Biology at Scripps Research, Dr. Cravatt is internationally recognized for his groundbreaking contributions to chemical biology and drug discovery. With over 70 years of dedication to neuroscience and more than a century since our founding, Lundbeck is uniquely positioned to co-create the future of brain health. Learn more and register here: lnkd.in/eBrPw927

Join us in Cambridge, MA on Sept. 16 for Lundbeck’s External Innovation & Partnering Event. Following the opening of our Cambridge innovation office, we’re bringing together leaders across neuroscience, biotech and life sciences to exchange ideas and build collaborations that can help shape the future of brain health. Learn more and register: lundbeck.com/global/external… #Neuroscience #Biotech

We're proud to be Certified as a @GPTW_US Great Place To Work for the 7th consecutive year! This recognition comes directly from our employees—93% of our US colleagues said Lundbeck is a great place to work. Thank you to our incredible team for bringing our purpose to life every day as we advance brain health and transform lives. #GPTWCertified #LifeAtLundbeck

We're proud to receive 8 Top Workplaces Culture Excellence Awards, including our first Leadership Culture Excellence Award! This recognition reflects our commitment to developing leaders who empower our people to grow, thrive, and succeed. We also earned repeat recognition for Innovation, Work-Life Flexibility, Compensation & Benefits, Purpose & Values, Professional Development, Employee Well-Being, and Employee Appreciation. These awards are especially meaningful because they're based on feedback from our employees and reflect the culture we've built together. #TopWorkplaces #CultureExcellence #LifeAtLundbeck

Leaders from the Lundbeck La Jolla Research Center (LLJRC) recently joined industry peers during the @PhRMA Researcher Fly-Ins, sharing Lundbeck's story as a focused innovator in neuroscience directly with state and federal policymakers. 📍 In Washington, D.C., Jake Wiener, Vice President and Site Head of LLJRC, represented Lundbeck during PhRMA’s Capitol Hill Fly-In, meeting with members of Congress and health policy staff, including @RepScottPeters, @RepMikeLevin and @Rep_Whitesides. 📍 In Sacramento, Jackie Blankman, Sr. Director, Biology and Deputy Site Head of LLJRC, joined researchers from 14 PhRMA member companies for meetings with state legislators and staff. Continued dialogue between policymakers and researchers is critical to advance scientific progress for patients. We're proud to contribute to the continued collaboration with our peers, the community and legislators. #PhRMAFlyIn26

We’re honored to be named one of @FortuneMagazine's Best Workplaces in Chicago, ranking No. 8 on this year’s large employers list and earning this recognition for the third consecutive year -- a great recognition of our people, who are united by a shared commitment to advancing brain health and transforming lives: greatplacetowork.com/best-wo… #Fortune #Chicago

According to the results of a recent collaborative survey between Lundbeck and the @AMFMigraine, the migraine patients surveyed trust their healthcare providers as the strongest source of guidance in managing migraine. By fostering meaningful dialogue and addressing the significant impact migraine disease has on quality of life, healthcare providers and patients can better address how to mitigate disease progression and focus on better symptom control. Here are some resources compiled by Lundbeck to help patients on their path to better days: bit.ly/3MtWyiB #RaiseTheBarForMigraine

Lundbeck presents new primary data from the Phase IIb PROCEED trial in migraine today at the @AHSheadache Annual Scientific Meeting. Read more about the data at #AHSAM and our commitment to advancing migraine care: bit.ly/43cWYyw **This post is intended for US audiences only.**

Attending #AHSAM? Drs. Gottschalk and @AmaalStarlingMD will discuss real-world patient-reported outcomes following previous anti-CGRP treatment failure in the Canary Ballroom, tomorrow at 12:30pm. Lunch will be served. #BrainHealth

New migraine data at @ahsheadache 2026 highlight real-world data and post-hoc analyses on the impact of disease-related symptoms. #AHSAM Read the full press release to learn more on what this means for patients: bit.ly/4x6JIZN

Attending #AHSAM? Join Lundbeck’s lunch symposium highlighting research on real-world patient-reported outcomes after anti-CGRP treatment failure, led by Drs. Christopher Gottschalk and @AmaalStarlingMD on Friday, June 5, 12:30pm. #BrainHealth

Did you know that migraine is a leading cause of disability worldwide? Over 60% of migraine patient respondents in the Lundbeck-sponsored Harris Poll Migraine Report Card survey reported experiencing anxiety and/or depression, highlighting the profound impact of this complex neurological disease that often effects many facets of life. Unfortunately, migraine is frequently underrecognized, fueling stigma. Lundbeck is raising awareness to breaking down stigma and advocating for better outcomes for migraine patients. Learn more about what patient resources are available: bit.ly/3MtWyiB #RaiseTheBarForMigraine

It's time to raise the bar for migraine care. In a recent collaborative survey with @AMFMigraine, 92% of respondents reported that migraine disease impacts their quality of life, and they want healthcare providers to better understand what that means for them. Patients and providers must foster meaningful conversations about disease impact, severity, and individualized goals. Together, we can redefine expectations for migraine care and improve quality of life for patients. Explore what resources are available to help you discuss migraine with your doctor: bit.ly/3MtWyiB #RaiseTheBarForMigraine

Results from the Phase II AMULET study of an investigational drug in patients with multiple system atrophy were recently published in @TheLancet Neurology. Learn more: bit.ly/3QBwmEh. *This post is intended for US audiences only*

Lundbeck, in collaboration with @AMFMigraine, created a survey to better understand patient experiences during provider visits, resulting in new insights on the important role healthcare providers play in initiating conversations about treatment options, goals setting, and shared decision making. Together, we can elevate care standards and address patients’ needs to improve outcomes for the migraine community. Get tools to help prepare for your next doctor’s visit: bit.ly/3MtWyiB #RaiseTheBarForMigraine

New interim real-world data on #migraine and related cognitive symptoms are being presented at @AANmember #AANAM today. Read the full press release to learn more on what this means for patients: Read the full press release: bit.ly/3OO2vb4

The Lundbeck-sponsored Harris Poll Migraine Report Card highlighted that, according to survey respondents, despite progress in treatment options, preventive care remains underutilized among patients whose migraine attack frequency qualifies them for preventive care. Updated professional society position statements emphasize the importance of using migraine-specific treatments. It’s time to Raise the Bar - patients and providers must elevate expectations for preventive care and foster meaningful dialogue around disease impact, severity, and individualized goals. Get the tools: bit.ly/3MtWyiB #RaiseTheBarForMigraine

Proud to share Thomas Gibbs, EVP & President, Lundbeck US, has been named a Notable Leader in Health Care by @CrainsChicago. Under his leadership, our team shows up every day Powered by Purpose. #AdvancingBrainHealth #TransformingLives #PoweredByPurpose

Lundbeck presents new data this week at the American Academy of Neurology Annual Meeting (#AANAM), spanning #migraine, developmental and epileptic encephalopathy (#DEE), and multiple system atrophy (#MSA). Together, these data highlight Lundbeck’s continued commitment to making progress in brain diseases with high unmet need. Learn more: bit.ly/4sOZGop **This post is intended for US audiences only.**